These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25591934)

  • 1. Role of osteopontin in the regulation of human bladder cancer proliferation and migration in T24 cells.
    Xu ST; Guo C; Ding X; Fan WJ; Zhang FH; Xu WL; Ma YC
    Mol Med Rep; 2015 May; 11(5):3701-7. PubMed ID: 25591934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 3.  Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
    Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
    Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of osteopontin downregulation on the growth of prostate cancer PC-3 cells.
    Zheng J; Hou ZB; Jiao NL
    Mol Med Rep; 2011; 4(6):1225-31. PubMed ID: 21842122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells].
    Liu H; Chen AM; Guo FJ; Liao H; Hu WH; Xie J
    Chin J Cancer; 2010 Jan; 29(1):43-51. PubMed ID: 20038310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
    Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
    Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of osteopontin as a therapeutic target for human colorectal cancer.
    Likui W; Hong W; Shuwen Z; Yuangang Y; Yan W
    J Gastrointest Surg; 2011 Apr; 15(4):652-9. PubMed ID: 21318445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin accelerates the development and metastasis of bladder cancer via activating JAK1/STAT1 pathway.
    Zhang N; Li F; Gao J; Zhang S; Wang Q
    Genes Genomics; 2020 Apr; 42(4):467-475. PubMed ID: 32088853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated vascular endothelial growth factor-C reduction suppresses malignant progression and enhances mitomycin C sensitivity of bladder cancer T24 cells.
    Zhang HH; Qi F; Shi YR; Miao JG; Zhou M; He W; Chen MF; Li Y; Zu XB; Qi L
    Cancer Biother Radiopharm; 2012 Jun; 27(5):291-8. PubMed ID: 21902544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells.
    Yang G; Zhang Y; Wu J; Xiong J; Deng H; Wang J; Yang C; Zhu Z
    Mol Med Rep; 2011; 4(6):1169-73. PubMed ID: 21785824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
    Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
    Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
    Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
    Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of phospholipase C-epsilon by short-hairpin RNA-mediated gene silencing induces apoptosis in human bladder cancer cell lines.
    Zhang Y; Yan L; Zhao Y; Ou L; Wu X; Luo C
    Cancer Biother Radiopharm; 2013 Apr; 28(3):233-9. PubMed ID: 23484808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer.
    Jiang X; Lei T; Zhang M
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618769413. PubMed ID: 29665744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.